tool
shrna
deliveri
gene
suppress
especi
target
cell
resist
transfect
dna
rna
avail
high
titer
adenovirus
uniform
rapid
infect
approach
would
forese
wide
applic
experiment
biolog
molecular
medicin
object
sever
acut
respiratori
syndrom
sar
highli
contagi
lethal
diseas
caus
new
type
coronaviru
sarsassoci
coronaviru
sarscov
current
effici
treatment
prevent
diseas
construct
recombin
adenovir
vector
express
shrna
inhibit
express
sarscov
gene
effect
mammalian
cell
method
studi
design
sever
plasmid
express
small
hairpin
rna
molecul
shrna
specif
target
gene
encod
sarscov
nucleocapsid
n
protein
envelop
e
protein
respect
effect
shrna
molecul
viral
gene
screen
identifi
construct
adenoviru
vector
effect
adenovirusdeliv
small
hairpin
rna
sarscov
gene
express
determin
rtpcr
western
blot
luciferas
activ
assay
result
level
viral
mrna
viral
protein
target
significantli
decreas
complet
inhibit
cell
line
infect
recombin
adenovirus
express
specif
shrna
molecul
conclus
sinc
mani
cell
type
effici
infect
adenoviru
recombin
adenovirus
could
serv
altern
power
end
june
sever
epidem
diseas
call
sever
acut
respiratori
syndrom
sar
broke
china
countri
known
sar
coronaviru
sarscov
novel
human
coronaviru
respons
sar
infect
sarscov
envelop
positivestrand
rna
viru
genom
compos
nucleotid
sar
genom
encod
put
protein
typic
coronaviru
replicas
rep
spike
membran
envelop
e
nucleocapsid
n
n
protein
sarscov
amino
acid
long
share
homolog
n
protein
coronavirus
previou
studi
indic
n
protein
coronavirus
varieti
function
activ
includ
particip
transcript
viral
genom
format
viral
core
packag
viral
rna
howev
similar
function
role
sarscov
report
except
sarscov
n
may
select
activ
pathway
furthermor
sarscov
n
protein
capabl
selfassoci
ctermin
interact
domain
e
protein
anoth
import
structur
protein
sarscov
recent
shown
play
major
role
coronaviru
assembl
rna
interfer
rnai
ancient
evolutionarili
conserv
process
ever
sinc
synthet
nucleotid
short
interf
rna
sirna
shown
induc
effici
rnai
mammalian
cell
sirna
routin
use
gene
silenc
transfect
chemic
synthes
sirna
specif
inhibit
cellular
mrna
rnai
trigger
mammalian
cell
introduct
sirna
current
rnai
technolog
report
ideal
tool
inhibit
infecti
viru
replic
host
cell
includ
polioviru
flock
hous
viru
rou
sarcoma
viru
dengu
viru
hepat
c
viru
replicon
influenza
viru
hepat
b
viru
sarscov
adenoviru
vector
wide
use
express
transgen
clinic
experiment
condit
adenoviru
sever
uniqu
featur
abil
infect
divid
nondivid
cell
lack
cellmedi
immun
respons
vector
abil
integr
host
chromosom
persist
episom
report
describ
construct
recombin
adenovir
vector
introduc
express
shrna
intracellularli
inhibit
express
sarscov
gene
effect
follow
two
pair
primer
use
amplifi
n
e
gene
fulllength
cdna
sarscov
sarscov
whu
genbank
access
respect
n
gene
sens
antisens
e
gene
sens
antisens
pcr
product
clone
bamhi
ecori
site
stratagen
gener
pcmvn
pcmve
also
use
follow
two
pair
primer
amplifi
fragment
carri
part
n
part
e
gene
pcr
product
clone
sal
bgl
ii
site
plucf
gener
plasmid
plucfn
fig
plucf
fig
b
n
e
gene
fuse
frame
luciferas
gene
express
fusion
gene
driven
cmv
promot
construct
confirm
dna
sequenc
target
sequenc
shrna
select
accord
webbas
criteria
analyz
blast
research
avoid
signific
homolog
endogen
cellular
gene
construct
singl
shrna
express
vector
two
primer
contain
target
sequenc
sens
antisens
strand
differ
region
n
gene
e
gene
fig
c
synthes
invitrogen
four
region
n
four
region
e
gene
select
respect
target
site
shrna
studi
sequenc
locat
list
follow
shrna
sens
antisens
oligonucleotid
selfcomplementari
hairpin
sequenc
contain
cohes
end
bam
hi
hin
diii
end
synthes
anneal
heat
c
min
slowli
cool
room
temperatur
eight
anneal
oligonucleotid
clone
bam
hi
hin
diii
site
plasmid
amibion
accord
manufactur
instruct
sequenc
construct
confirm
dna
sequenc
enhanc
deliveri
effici
shrna
recombin
adenovirus
gener
follow
step
pctrl
plasmid
digest
eco
ri
hin
diii
releas
small
fragment
contain
promot
target
sequenc
ligat
padtrack
ecor
hin
diii
site
gener
recombin
plasmid
adctrl
respect
recombin
padtrack
linear
pme
transform
cell
carri
plasmid
posit
clone
select
confirm
paci
digest
plasmid
correct
clone
amplifi
transform
cell
result
adenovir
dna
linear
pac
transfect
cell
sixwel
plate
use
sofast
tm
transfect
reagent
xiamen
sunma
biotechnolog
co
ltd
pr
china
produc
recombin
adenovirus
adctrl
respect
eight
day
transfect
recombin
viru
amplifi
titer
accord
manufactur
instruct
cell
maintain
dulbecco
modifi
eagl
medium
gibcobrl
supplement
unitsml
penicillin
gml
streptomycin
heatinactiv
fetal
bovin
serum
c
co
cell
seed
onto
plate
densiti
per
plate
plate
grown
confluenc
reach
approxim
time
transfect
cell
transfect
g
plasmid
contain
n
e
gene
togeth
g
shrna
express
plasmid
use
sofast
tm
transfect
reagent
cell
harvest
h
transfect
adenoviru
infect
cell
incub
recombin
viru
moi
c
adsorpt
h
fresh
growth
medium
ad
cell
place
incub
addit
day
cell
cotransfect
report
plasmid
shrna
express
plasmid
cell
wash
pb
lyse
luciferas
cell
cultur
lysi
reagent
promega
l
cell
lysat
l
luciferas
assay
substrat
promega
mix
fluoresc
intens
detect
luminomet
turner
assay
perform
triplic
express
mean
sd
rel
vector
control
cell
cotransfect
pcmvn
pcmve
plasmid
shrna
express
plasmid
total
rna
extract
transfect
cell
trizol
reagent
invitrogen
accord
method
describ
manufactur
manual
revers
transcript
perform
total
rna
templat
specif
mrna
amplifi
rtpcr
use
specif
primer
n
e
gene
product
band
visual
quantifi
use
kodak
imag
system
rel
mrna
express
estim
normal
actin
control
signal
intens
control
vector
consid
cell
harvest
indic
time
point
wash
cold
pb
lyse
lysi
buffer
pb
edta
triton
contain
proteas
inhibitor
cocktail
roch
usa
total
protein
separ
sdspolyacrylamid
gel
transfer
onto
nylon
membran
incub
antiflag
sigma
usa
monoclon
antibodi
follow
incub
peroxidaseconjug
immunopur
goat
antimous
secondari
antibodi
pierc
usa
band
visual
use
supersign
west
pico
chemiluminesc
substrat
pierc
usa
densitometr
scan
xray
film
perform
protein
express
level
determin
normal
actin
use
kodak
imag
system
signal
intens
control
vector
consid
effici
screen
shrna
molecul
select
target
dna
sequenc
fuse
frame
luciferas
gene
luciferas
activ
suppos
repres
level
n
e
mrna
express
cell
cotransfect
plucfn
plucf
eight
singl
shrna
express
vector
respect
luciferas
activ
determin
transfect
cell
cell
result
show
strongli
inhibit
luciferas
activ
respect
compar
random
sequencescrambl
shrna
control
fig
b
similar
result
obtain
cell
fig
b
result
indic
four
shrna
effect
degrad
fusion
mrna
nluciferas
eluciferas
determin
effect
shrna
rna
express
level
total
rna
isol
transfect
cell
use
templat
synthes
cdna
specif
mrna
amplifi
rtpcr
use
genespecif
primer
n
fig
c
e
fig
b
actin
use
endogen
control
pcr
product
detect
agaros
gel
electrophoresi
visual
uv
light
quantifi
use
kodak
imag
system
rel
fig
lane
fig
lane
fig
lane
respect
level
e
mrna
also
decreas
treatment
fig
b
lane
vector
fig
lane
fig
b
lane
untreat
cell
fig
lane
fig
b
lane
similar
result
also
obtain
cell
condit
shrna
treatment
fig
c
level
n
mrna
dramat
reduc
cell
treatment
fig
c
lane
fig
c
lane
fig
c
lane
respect
level
e
mrna
cell
also
reduc
treatment
fig
lane
determin
effect
shrna
viral
rna
express
total
rna
isol
transfect
cell
use
templat
synthes
cdna
specif
mrna
amplifi
rtpcr
use
specif
primer
n
gene
fig
c
e
e
genespecif
primer
fig
f
actin
gene
endogen
control
pcr
product
detect
agaros
gel
electrophoresi
visual
uv
light
vector
fig
c
lane
fig
lane
untreat
cell
fig
c
lane
fig
lane
determin
whether
shrna
specif
reduc
n
e
protein
express
western
blot
appli
analyz
level
flagtag
n
e
protein
fig
b
fig
c
cell
use
antiflag
antibodi
result
show
decreas
level
protein
correl
rtpcr
assay
cell
line
enhanc
effect
shrna
deliveri
investig
therapeut
feasibl
shrna
gener
shrnaexpress
recombin
adenoviru
data
shown
target
differ
locat
n
e
gene
also
gener
neg
control
express
random
se
c
transduct
shrnaexpress
adenovirus
dosedepend
reduc
express
target
gene
target
mrna
protein
analyz
rtpcr
fig
e
f
western
blot
analysi
fig
e
f
parallel
result
indic
reduct
observ
transduct
shrnaexpress
adenovirus
compar
transfect
shrnaexpress
plasmid
sar
newli
emerg
infecti
diseas
usual
character
fever
dri
cough
myalgia
mild
sore
throat
progress
typic
pneumonia
sar
case
sarsrel
death
report
countri
around
world
http
wwwwhointcsrsarscountryen
sar
danger
high
morbid
mortal
rate
sar
caus
newli
identifi
viru
within
famili
coronavirida
viru
design
sar
coronaviru
sarscov
present
sever
potenti
sar
therapi
develop
vaccin
interferon
use
rnai
technolog
therapi
sar
would
advantag
specif
target
gene
minim
side
effect
potenti
prove
use
novel
treatment
virusinduc
diseas
although
problem
effici
deliv
small
interf
rna
express
vector
small
interf
rna
target
host
cell
remain
resolv
interfer
sarscov
gene
express
induc
use
sirna
duplex
transient
high
sequenc
specif
sirnamedi
rna
degrad
antivir
efficaci
sirna
direct
viral
genom
larg
limit
emerg
escap
variant
resist
sirna
due
high
mutat
rate
viru
especi
rna
virus
polioviru
hepat
c
viru
sarscov
problem
circumv
target
multipl
essenti
gene
virus
increas
deliveri
effici
sirna
among
approach
perhap
desir
one
choos
adenovir
vector
express
system
result
demonstr
inhibit
sarscov
gene
achiev
adenovirusdeliv
sirna
studi
examin
gene
inhibit
adenovir
system
cell
possibl
approach
may
applic
type
cell
well
especi
primari
cell
limit
lifespan
resist
transfect
high
effici
adenovir
infect
varieti
host
cell
type
may
render
approach
conveni
method
achiev
gene
inhibit
cellular
express
shrna
also
provid
possibl
appli
techniqu
anim
model
investig
conclus
develop
simpl
shrna
deliveri
strategi
combin
welldefin
promot
convent
adenoviru
system
result
demonstr
signific
inhibit
viral
gene
achiev
mammalian
cell
sinc
mani
cell
type
effici
infect
adenoviru
recombin
adenovirus
could
serv
altern
power
tool
deliveri
shrna
gene
suppress
especi
target
cell
resist
transfect
dna
rna
addit
find
also
provid
solid
evid
develop
antisarscov
therapi
use
adenovirusdeliv
small
hairpin
rna
may
enhanc
antisarscov
efficaci
overcom
drug
resist
avail
high
titer
adenovirus
uniform
rapid
infect
technolog
forese
wide
applic
experiment
biolog
molecular
medicin
